Medifast Inc expected to post a loss of 35 cents a share - Earnings Preview
Medifast Inc expected to post a loss of 35 cents a share - Earnings Preview
Medifast Inc MED.N, MED is expected to show a fall in quarterly revenue when it reports results on October 26 for the period ending September 30 2026
The Baltimore Maryland-based company is expected to report a 20.3% decrease in revenue to $71.3 million from $89.41 million a year ago, according to the estimate from one analyst, based on LSEG data.The company's guidance on August 3 2026, for the period ended September 30, was for revenue between $60.00 million and $80.00 million.
LSEG's mean analyst estimate for Medifast Inc is for a loss of 35 cents per share. The company's EPS guidance on August 3 2026, for the period ended September 30, was between $-0.65 and $-0.15
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Medifast Inc is $12.00, about 1.4% below its last closing price of $12.17
This summary was machine generated October 23 at 12:50 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Medifast
See all newsMedifast Inc expected to post a loss of 35 cents a share - Earnings Preview
Medifast Inc reports results for the quarter ended June 30 - Earnings Summary
Medifast Q2 revenue falls 28% as active coaches drop
Brief: Medifast Q2 Revenue USD 76.384 Million
Medifast Inc expected to post a loss of 65 cents a share - Earnings Preview